Biotech Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Gene Therapy
Tumor cell motility is modulated by MAP4K4 promigratory kinase
May 18th, 2006
According to recent research from the United States, tumor cell motility is modulated by MAP4K4 promigratory kinase. "Cell motility is a complex biological process, involved in development, inflammation, homeostasis, and pathological processes such as the invasion and metastatic spread of cancer. Here, we describe a genomic screen designed to identify inhibitors of cell migration," wrote C.S. Collins and colleagues, Celgene Signal Research. "A library of 10,996 small interfering RNAs (targeting 5,234 human genes) was screened for their ability to block the migration of a highly motile ovarian carcinoma cell line, SKOV-3, by using a 384-well...
Source: Biotech Business Week (2006-05-18)
|
